JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

Search

Baxter International Inc

Suletud

SektorTervishoid

21.03 5.63

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

19.91

Max

21.12

Põhinäitajad

By Trading Economics

Sissetulek

-173M

-51M

Müük

25M

2.8B

P/E

Sektori keskmine

86.308

84.243

Dividenditootlus

3.39

Kasumimarginaal

-1.799

Töötajad

38,000

EBITDA

-46M

416M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+11.42% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

3.39%

2.28%

Järgmine tulemuste avaldamine

12. veebr 2026

Järgmine dividendimakse kuupäev

31. märts 2026

Järgmine aktsia dividendi kuupäev (ex-date)

27. veebr 2026

Turustatistika

By TradingEconomics

Turukapital

-1.7B

10B

Eelmine avamishind

15.4

Eelmine sulgemishind

21.03

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

Baxter International Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

5. veebr 2026, 00:00 UTC

Kuumad aktsiad

Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul

4. veebr 2026, 22:55 UTC

Tulu

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update

4. veebr 2026, 21:44 UTC

Tulu

Arm Holdings 3Q Profit Falls Despite Revenue Growth

4. veebr 2026, 21:39 UTC

Tulu

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook

5. veebr 2026, 00:00 UTC

Tulu

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

5. veebr 2026, 00:00 UTC

Tulu

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

4. veebr 2026, 23:46 UTC

Market Talk

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

4. veebr 2026, 23:45 UTC

Tulu

Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update

4. veebr 2026, 23:32 UTC

Market Talk

Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk

4. veebr 2026, 22:59 UTC

Omandamised, ülevõtmised, äriostud

SiTime to Buy Timing Business From Renesas Electronics For $1.5B

4. veebr 2026, 22:30 UTC

Tulu

Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com

4. veebr 2026, 22:30 UTC

Tulu

Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com

4. veebr 2026, 22:21 UTC

Tulu

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4. veebr 2026, 22:17 UTC

Market Talk

WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk

4. veebr 2026, 22:15 UTC

Market Talk

Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk

4. veebr 2026, 22:00 UTC

Market Talk

ESG Roundup: Market Talk

4. veebr 2026, 21:53 UTC

Tulu

Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update

4. veebr 2026, 21:51 UTC

Tulu

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4. veebr 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4. veebr 2026, 21:50 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Financial Services Roundup: Market Talk

4. veebr 2026, 21:50 UTC

Market Talk
Tulu

Auto & Transport Roundup: Market Talk

4. veebr 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

4. veebr 2026, 21:45 UTC

Tulu

Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com

4. veebr 2026, 21:44 UTC

Tulu

Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com

4. veebr 2026, 21:43 UTC

Tulu

Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update

4. veebr 2026, 21:41 UTC

Tulu

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4. veebr 2026, 21:36 UTC

Market Talk

Latest Canada Green Bond Raises C$2 Billion -- Market Talk

4. veebr 2026, 21:30 UTC

Tulu

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4. veebr 2026, 21:30 UTC

Tulu

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4. veebr 2026, 21:30 UTC

Tulu

Beach Energy Interim Dividend 1 Australian Cent/Sjare

Võrdlus sarnastega

Hinnamuutus

Baxter International Inc Prognoos

Hinnasiht

By TipRanks

11.42% tõus

12 kuu keskmine prognoos

Keskmine 22.14 USD  11.42%

Kõrge 30 USD

Madal 15 USD

Põhineb 7 Wall Streeti analüütiku instrumendi Baxter International Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

7 ratings

2

Osta

4

Hoia

1

Müü

Tehniline skoor

By Trading Central

30.475 / 31.345Toetus ja vastupanu

Lühikene perspektiiv

Weak Bullish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Baxter International Inc

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
help-icon Live chat